The report compares India’s non-clinical drug approval framework with regulatory practices in the US, European Union, the UK ...
Scholars warn that replacing animal testing too quickly may threaten drug safety. As the FDA promotes AI and organoids, ...
(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near ...
A groundbreaking multi-stakeholder report reveals that transitioning to Non-Animal Methods (NAMs) can reduce drug development ...
(Reuters) — The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with “human-relevant methods,” ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DENVER (KDVR) — Gov. Jared Polis recently ...
India is urged to adopt cruelty-free, science-driven drug testing methods to boost its pharmaceutical industry. A new report ...
In a year from now, progress is to be measured in the institutionalisation of the approach with greater regulatory acceptance ...
The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with human-based methods. The agency said the new approach will aim to improve drug ...
Experts urge India to adopt non-animal methods for pre-clinical drug testing to enhance ethics, efficiency, and scientific relevance.
Our Bureau, Bengaluru Friday, February 6, 2026, 09:00 Hrs [IST] ...
Dr Reddy's, Biocon and Sun Pharma are exploring human-based testing methods that could halve drug development timelines and sharply reduce costs, while meeting global regulatory standards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results